Search

everythinglearnresearchcommunity

for

Search:↓

The wigs made from human hair and polypropylene were mostly well-tolerated and durable in rabbits, suggesting they could be a new option for people with extensive hair loss.

Switching immunosuppressive drugs can improve hair regrowth and well-being in transplant patients with hair loss.

Intraoperative corticosteroids reduce swelling, and early care lowers folliculitis risk in hair transplant donor sites.

New treatments for epidermolysis bullosa show promise in improving patients' lives, but a cure is still not available.

Mesenchymal stem cells can effectively aid skin healing and anti-aging.

Certain HSD3B1 gene types are linked to worse prostate cancer outcomes and affect treatment response and other health conditions.

Gene knockout mice developed scars similar to human hypertrophic scars, useful for studying scar progression.

The hepatitis B vaccine did not cause hair loss in the tested mice.

All types of Platelet-Rich Plasma (PRP) can treat hair loss, but homologous PRP works best due to its higher platelet count and growth factors from multiple donors.

Scientists found a new gene in a bacterium that can modify an immunosuppressant drug, potentially helping to treat hair loss.

Patient-derived stem cell melanocytes could be a promising treatment for vitiligo.

Recycling hair from past transplants can improve hair density and patient satisfaction.

Scientists identified a unique type of human skin stem cell that could help with tissue repair.

Blocking interferon-gamma helps prevent and treat hair loss in Alopecia Areata.

Chronic graft-versus-host disease in the skin shows strong Th1 immune response and unique barrier issues.

Improving mesenchymal stromal cell therapies requires overcoming cell death and optimizing delivery methods.

DHL-HisZnNa may help reduce hair loss from chemotherapy, but more research is needed.

iNKT cells can help prevent and treat alopecia areata by promoting hair regrowth.

Hidradenitis Suppurativa has genetic links, with certain gene mutations more common in patients and a third of cases having a family history.

Since 1995, we only use Follicular Unit Transplantation for hair restoration and stopped using minigrafting/micrografting techniques.

γδ T cells can prevent and treat alopecia areata, offering a new therapy option.

A patient with advanced kidney cancer and no hepatitis C developed skin inflammation due to a drug called interferon alpha-2a.

Corticosteroid pulse therapy is more effective for severe alopecia areata than combination therapy.

Serum from alopecia patients does not stop hair growth in grafted skin on mice.

Transplanting a mix of specific skin cells can significantly improve the repair of damaged hair follicles.

ADSC-enriched fat grafting is the best and safest aesthetic treatment, combining effectiveness and ethical confidence.

The Enriched-GF method efficiently produces high-yield growth factors for tissue repair.

The C3H/HeJ mouse model is useful for studying and testing treatments for alopecia areata.

Exogenous stem cells can effectively integrate into hair follicles, promoting hair growth.

Recombinant gonadotropins improve future fertility in CHH patients.